Touchstone Capital’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-251,625
Closed -$9.95M 30
2023
Q4
$9.95M Sell
251,625
-16,736
-6% -$701K 9.46% 4
2023
Q3
$11.9M Sell
268,361
-1,408
-0.5% -$61.4K 13.15% 2
2023
Q2
$11.7M Sell
269,769
-3,173
-1% -$140K 12.43% 3
2023
Q1
$11.9M Sell
272,942
-788
-0.3% -$34.8K 13.11% 2
2022
Q4
$10.2M Sell
273,730
-11,775
-4% -$456K 11.92% 3
2022
Q3
$11.4M Buy
285,505
+1,541
+0.5% +$57K 13.26% 2
2022
Q2
$10.9M Buy
283,964
+4,123
+1% +$149K 10.74% 2
2022
Q1
$11.1M Buy
279,841
+4,424
+2% +$173K 9.56% 4
2021
Q4
$11.4M Buy
275,417
+65,855
+31% +$2.86M 9.16% 4
2021
Q3
$8.84M Buy
209,562
+1,465
+0.7% +$73.8K 8.05% 6
2021
Q2
$9.55M Buy
+208,097
New +$9.9M 8.63% 5

Other funds holding NRC

Touchstone Capital's NRC Position: Q1 2024 in Review

Touchstone Capital sold out of NRC Health Common Stock (NRC) in Q1 2024, closing a stake of 251,625 shares — an estimated $9.95M sold.

Touchstone Capital first reported a position in NRC in Q2 2021 and held it in 11 quarters. The position peaked at $11.9M in Q3 2023. 142 funds tracked by Wall St. Rank hold NRC as of Q1 2024.

  • Touchstone Capital reported no remaining NRC Health Common Stock position as of Q1 2024 after selling out during the quarter.
  • Touchstone Capital sold 251,625 NRC Health Common Stock shares in Q1 2024, an estimated $9.95M.
  • Touchstone Capital first reported a position in NRC Health Common Stock in Q2 2021 and held it in 11 quarters.
  • Touchstone Capital's NRC Health Common Stock position peaked at $11.9M in Q3 2023.
  • 142 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2024.

Based on Touchstone Capital's 13F filing for Q1 2024, filed 16 Apr 2024.